These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35948470)

  • 1. Effects of omega-3 supplementation on quality of life, nutritional status, inflammatory parameters, lipid profile, exercise tolerance and inhaled medications in chronic obstructive pulmonary disease.
    Fekete M; Szarvas Z; Fazekas-Pongor V; Lehoczki A; Tarantini S; Varga JT
    Ann Palliat Med; 2022 Sep; 11(9):2819-2829. PubMed ID: 35948470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical value of omega-3 polyunsaturated fatty acid supplementation in chronic obstructive pulmonary disease].
    Fekete M; Szőllősi G; Németh AN; Varga JT
    Orv Hetil; 2021 Jan; 162(1):23-30. PubMed ID: 33388735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD.
    Matsuyama W; Mitsuyama H; Watanabe M; Oonakahara K; Higashimoto I; Osame M; Arimura K
    Chest; 2005 Dec; 128(6):3817-27. PubMed ID: 16354850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.
    Broekhuizen R; Wouters EF; Creutzberg EC; Weling-Scheepers CA; Schols AM
    Thorax; 2005 May; 60(5):376-82. PubMed ID: 15860712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD.
    de Batlle J; Sauleda J; Balcells E; Gómez FP; Méndez M; Rodriguez E; Barreiro E; Ferrer JJ; Romieu I; Gea J; Antó JM; Garcia-Aymerich J;
    J Nutr Biochem; 2012 Jul; 23(7):817-21. PubMed ID: 21889886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease: a systematic review.
    Atlantis E; Cochrane B
    Int J Evid Based Healthc; 2016 Jun; 14(2):53-63. PubMed ID: 26134547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 13. Physical activity in COPD patients decreases short-acting bronchodilator use and the number of exacerbations.
    Katajisto M; Koskela J; Lindqvist A; Kilpeläinen M; Laitinen T
    Respir Med; 2015 Oct; 109(10):1320-5. PubMed ID: 26298024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 Fatty Acids Improve Chronic Kidney Disease-Associated Pruritus and Inflammation.
    Lin YL; Wang CL; Liu KL; Yeh CN; Chiang TI
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Chinese herb formula Yufeining on stable chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial.
    Hong M; Hong C; Chen H; Ke G; Huang J; Huang X; Liu Y; Li F; Li C
    Medicine (Baltimore); 2018 Sep; 97(39):e12461. PubMed ID: 30278529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial.
    Silva PS; Sperandio da Silva GM; de Souza AP; Cardoso CS; Fonseca CA; Brito PD; Saraiva RM; Brasil PE; Pinheiro RO; Hasslocher-Moreno AM; Xavier SS; Sousa AS
    Trials; 2013 Nov; 14():379. PubMed ID: 24216069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between polyunsaturated fatty acids and chronic obstructive pulmonary disease: a meta-analysis.
    Piao Z; Chai B; Wu Y; Diao H; He Q; Zheng Q; Yan F; Cui W
    Food Funct; 2024 Jun; 15(11):5929-5941. PubMed ID: 38738702
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between polyunsaturated fatty acids and inflammatory markers in patients in secondary prevention of cardiovascular disease.
    Bersch-Ferreira ÂC; Sampaio GR; Gehringer MO; Ross-Fernandes MB; Kovacs C; Alves R; Pereira JL; Magnoni CD; Weber B; Rogero MM
    Nutrition; 2017 May; 37():30-36. PubMed ID: 28359359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.